WDB coco CO.,LTD. Logo

WDB coco CO.,LTD.

A CRO providing support services to the pharmaceutical and medical device sectors.

7079 | T

Overview

Corporate Details

ISIN(s):
JP3506010002
LEI:
Country:
Japan
Address:
中央区晴海一丁目8−11

Description

WDB coco CO.,LTD. is a Contract Research Organization (CRO) that provides comprehensive support services to the pharmaceutical and medical device sectors. The company's core expertise lies in safety information management (pharmacovigilance) and post-marketing surveillance (PMS). It also offers a range of other services, including support for clinical research, medical device development, and document preparation for clinical trials, regulatory approval applications, and quality assurance. The company supports clients throughout the product lifecycle, from development and application to post-market activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-14 01:35
四半期報告書-第41期第2四半期(2023/07/01-2023/09/30)
Japanese 178.7 KB
2023-08-10 03:59
確認書
Japanese 8.7 KB
2023-08-10 03:54
四半期報告書-第41期第1四半期(2023/04/01-2023/06/30)
Japanese 147.2 KB
2023-06-27 04:53
内部統制報告書-第40期(2022/04/01-2023/03/31)
Japanese 22.7 KB
2023-06-27 04:49
確認書
Japanese 8.7 KB
2023-06-27 04:43
有価証券報告書-第40期(2022/04/01-2023/03/31)
Japanese 945.5 KB
2023-02-14 02:08
確認書
Japanese 8.7 KB
2023-02-14 02:03
四半期報告書-第40期第3四半期(2022/10/01-2022/12/31)
Japanese 142.8 KB
2022-11-14 01:54
確認書
Japanese 8.8 KB
2022-11-14 01:52
四半期報告書-第40期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 175.5 KB
2022-08-10 09:22
確認書
Japanese 8.8 KB
2022-08-10 09:15
四半期報告書-第40期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 143.1 KB
2022-06-27 04:30
内部統制報告書-第39期(令和3年4月1日-令和4年3月31日)
Japanese 22.3 KB
2022-06-27 04:00
確認書
Japanese 8.7 KB
2022-06-27 03:51
有価証券報告書-第39期(令和3年4月1日-令和4年3月31日)
Japanese 920.8 KB

Automate Your Workflow. Get a real-time feed of all WDB coco CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WDB coco CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WDB coco CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.